Rexulti, the first drug to relieve Alzheimer's emotions - TimesKuwait

The US Food and Drug Administration (FDA) has granted fast-track approval of the first drug aimed at relieving the emotions associated with Alzheimer’s disease. The FDA published, on its official website, a statement confirming the approval of Otsuka Pharmaceutical Company and Lundbeck, producers of oral Rexulti tablets to relieve the emotions associated with Alzheimer’s disease, […]

FDA Approves the First Drug for Alzheimer's Agitation: Rexulti

FDA Approves the First Drug for Alzheimer's Agitation: Rexulti

Dementia: FDA fast-tracks approval for antipsychotic drug Rexulti

This Antipsychotic Drug Can Now Be Used to Treat Agitation in Alzheimer's Patients

Otsuka and Lundbeck Announce REXULTI for Alzheimer's Agitation

FDA approves Rexulti for agitation tied to Alzheimer's dementia, Daily therapy is first to be approved for this use in US

FDA Approves the First Drug for Alzheimer's Agitation: Rexulti

agitation that may happen with dementia due to Alzheimer's disease Questionnaire

This Antipsychotic Drug Can Now Be Used to Treat Agitation in Alzheimer's Patients

REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

FDA approves Rexulti for agitation tied to Alzheimer's dementia, Daily therapy is first to be approved for this use in US